Skip to main content
Erschienen in: World Journal of Surgery 4/2021

12.01.2021 | Original Scientific Report

Compromised Gut Associated Lymphoid Tissue is a Risk Factor for Postoperative Septic Complications in HIV-Seropositive Trauma Patients

verfasst von: Martin Mauser, Deirdré Kruger, Sugeshnee Pather, Frank Plani

Erschienen in: World Journal of Surgery | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The gut associated lymphoid tissue (GALT) is an important part of the immune system and compromised in HIV treatment-naïve as well as in HIV-seropositive patients on antiretroviral treatment (ART) due to HIV-induced changes. The influence of the impaired GALT on the postoperative complication rate after surgery for penetrating abdominal trauma has not been investigated and the hypothesis that the HIV-induced changes of the GALT contribute to septic complications postoperatively was tested.

Material and methods

This prospective study included patients who required a small bowel resection due to abdominal gunshot wounds. A bowel specimen was obtained in the index operation, and the T-lymphocytic quantity in the specimen was analyzed via immunohistochemistry to scrutinize whether these lymphocyte numbers had an impact on the postoperative outcome. Septic and postoperative complications were documented during the in-hospital course and the first month after discharge.

Results

In total, 62 patients were included in the study of which 38 patients were HIV-seronegative and 24 were HIV-seropositive. HIV-seropositive patients had a significantly lower quantity of CD4 + T cells in the GALT compared to the HIV-seronegative patients (p = 0.0001), which was also associated with a significantly higher rate of septic complications in the postoperative course. In the HIV-seropositive group, no significant differences were detected for T-lymphocytic quantity in the GALT between the HIV-treatment naïve and antiretroviral treatment groups.

Conclusion

The compromised GALT in HIV-seropositive patients may predispose these patients to postoperative septic complications. Antiretroviral therapy does not result in an adequate immune reconstitution in this tissue.
Literatur
1.
Zurück zum Zitat Saltzman DJ, Williams RA, Gelfand DV et al (2005) The surgeon and AIDS. Arch Surg 140(10):961–967CrossRef Saltzman DJ, Williams RA, Gelfand DV et al (2005) The surgeon and AIDS. Arch Surg 140(10):961–967CrossRef
2.
Zurück zum Zitat Sabin CA (2013) Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? BMC Med 11(1):1–7CrossRef Sabin CA (2013) Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? BMC Med 11(1):1–7CrossRef
3.
Zurück zum Zitat Horberg MA, Hurley LB, Klein DB et al (2006) Surgical outcomes in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy. Arch Surg 141(12):1238–1245CrossRef Horberg MA, Hurley LB, Klein DB et al (2006) Surgical outcomes in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy. Arch Surg 141(12):1238–1245CrossRef
5.
Zurück zum Zitat Wiseman SM, Forrest JI, Chan JE, Zhang W et al (2012) Factors predictive of 30 day postoperative mortality in HIV/AIDS patients in the era of highly active antiretroviral therapy. Ann Surg 256(1):170–176CrossRef Wiseman SM, Forrest JI, Chan JE, Zhang W et al (2012) Factors predictive of 30 day postoperative mortality in HIV/AIDS patients in the era of highly active antiretroviral therapy. Ann Surg 256(1):170–176CrossRef
6.
Zurück zum Zitat Brenchley JM, Douek DC (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1(1):23–30CrossRef Brenchley JM, Douek DC (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1(1):23–30CrossRef
7.
Zurück zum Zitat Brenchley JM, Price DA, Douek DC (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7(3):235–240CrossRef Brenchley JM, Price DA, Douek DC (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7(3):235–240CrossRef
8.
Zurück zum Zitat Moore EE, Dunn EL, Moore JB et al (1981) Penetrating abdominal trauma index. J Trauma 21(6):439–445PubMed Moore EE, Dunn EL, Moore JB et al (1981) Penetrating abdominal trauma index. J Trauma 21(6):439–445PubMed
9.
Zurück zum Zitat Gomez-Leon JF (2004) Penetrating abdominal trauma index: sensitivity and specificity for morbidity and mortality by ROC analysis. Indian J Surg 66(6):347–351 Gomez-Leon JF (2004) Penetrating abdominal trauma index: sensitivity and specificity for morbidity and mortality by ROC analysis. Indian J Surg 66(6):347–351
10.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef
11.
Zurück zum Zitat Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRef Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRef
12.
Zurück zum Zitat Mehandru S (2007) The gastrointestinal tract in HIV-1 Infection: questions, answers, and more questions! PRN Noteb 12:88–98 Mehandru S (2007) The gastrointestinal tract in HIV-1 Infection: questions, answers, and more questions! PRN Noteb 12:88–98
13.
Zurück zum Zitat Mehandru S, Poles MA, Tenner-Racz K et al (2006) Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 3(12):e484CrossRef Mehandru S, Poles MA, Tenner-Racz K et al (2006) Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 3(12):e484CrossRef
14.
Zurück zum Zitat Pandrea I, Gaufin T, Gautam R et al (2011) Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+T cells and is reverted by CD8+cell depletion. PLoS Pathog 7(8):e1002170CrossRef Pandrea I, Gaufin T, Gautam R et al (2011) Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+T cells and is reverted by CD8+cell depletion. PLoS Pathog 7(8):e1002170CrossRef
15.
Zurück zum Zitat Streeck H, Lu R, Beckwith N et al (2014) Emergence of individual HIV-specific CD8 T Cell responses during primary HIV-1 Infection can determine long-term disease outcome. J Virol 88(21):12793–12801CrossRef Streeck H, Lu R, Beckwith N et al (2014) Emergence of individual HIV-specific CD8 T Cell responses during primary HIV-1 Infection can determine long-term disease outcome. J Virol 88(21):12793–12801CrossRef
16.
Zurück zum Zitat Guadalupe M, Reay E, Sankaran S et al (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77(21):11708–11717CrossRef Guadalupe M, Reay E, Sankaran S et al (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77(21):11708–11717CrossRef
17.
Zurück zum Zitat Pantaleo G, Demarest JF, Soudeyns H et al (1994) Major expansion of CD8 T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370(6489):463–467CrossRef Pantaleo G, Demarest JF, Soudeyns H et al (1994) Major expansion of CD8 T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370(6489):463–467CrossRef
18.
Zurück zum Zitat Guadalupe M, Sankaran S, George MD et al (2006) Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 80(16):8236–8247CrossRef Guadalupe M, Sankaran S, George MD et al (2006) Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 80(16):8236–8247CrossRef
19.
Zurück zum Zitat Shacklett BL, Cox CA, Sandberg JK et al (2003) Trafficking of human immunodeficiency virus type 1-specific CD8+T cells to gut-associated lymphoid tissue during chronic infection. J Virol 77(10):5621–5631CrossRef Shacklett BL, Cox CA, Sandberg JK et al (2003) Trafficking of human immunodeficiency virus type 1-specific CD8+T cells to gut-associated lymphoid tissue during chronic infection. J Virol 77(10):5621–5631CrossRef
20.
Zurück zum Zitat Yamamura Y, Gupta R, Morita Y et al (2001) Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 166(4):2270–2275CrossRef Yamamura Y, Gupta R, Morita Y et al (2001) Effector function of resting T cells: activation of synovial fibroblasts. J Immunol 166(4):2270–2275CrossRef
21.
Zurück zum Zitat Davis PA, Corless DJ, Aspinall R et al (2001) Effect of CD4+ and CD8+ cell depletion on wound healing. Br J Surg 88(2):298–304CrossRef Davis PA, Corless DJ, Aspinall R et al (2001) Effect of CD4+ and CD8+ cell depletion on wound healing. Br J Surg 88(2):298–304CrossRef
22.
Zurück zum Zitat Gautreaux MD, Deitch EA, Berg RD (1994) T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 62(7):2874–2884CrossRef Gautreaux MD, Deitch EA, Berg RD (1994) T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 62(7):2874–2884CrossRef
23.
Zurück zum Zitat Deneve JL, Shantha JG, Page AJ et al (2010) CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations. Am J Surg 200(6):694–699CrossRef Deneve JL, Shantha JG, Page AJ et al (2010) CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations. Am J Surg 200(6):694–699CrossRef
24.
Zurück zum Zitat Shanthamurthy D, Manesh A, Zacchaeus NG et al (2018) Perioperative outcomes in human immunodeficiency virus-infected patients-the PRO HIV study. Int J STD AIDS 29(10):968–973CrossRef Shanthamurthy D, Manesh A, Zacchaeus NG et al (2018) Perioperative outcomes in human immunodeficiency virus-infected patients-the PRO HIV study. Int J STD AIDS 29(10):968–973CrossRef
25.
Zurück zum Zitat Grubert TA, Reindell D, Kästner R et al (2002) Rates of postoperative complications among human immunodeficiency virus–infected women who have undergone obstetric and gynecologic surgical procedures. Clin Infect Dis 34(6):822–830CrossRef Grubert TA, Reindell D, Kästner R et al (2002) Rates of postoperative complications among human immunodeficiency virus–infected women who have undergone obstetric and gynecologic surgical procedures. Clin Infect Dis 34(6):822–830CrossRef
26.
Zurück zum Zitat Beharka AA, Paiva S, Leka LS et al (2001) Effect of age on the gastrointestinal-associated mucosal immune response of humans. J Gerontol 56A(5):B218–B223CrossRef Beharka AA, Paiva S, Leka LS et al (2001) Effect of age on the gastrointestinal-associated mucosal immune response of humans. J Gerontol 56A(5):B218–B223CrossRef
27.
Zurück zum Zitat Mauser M, Bartsokas C, Brand M et al (2018) Postoperative CD4 counts predict anastomotic leaks in patients with penetrating abdominal trauma. Injury 50(1):167–172CrossRef Mauser M, Bartsokas C, Brand M et al (2018) Postoperative CD4 counts predict anastomotic leaks in patients with penetrating abdominal trauma. Injury 50(1):167–172CrossRef
Metadaten
Titel
Compromised Gut Associated Lymphoid Tissue is a Risk Factor for Postoperative Septic Complications in HIV-Seropositive Trauma Patients
verfasst von
Martin Mauser
Deirdré Kruger
Sugeshnee Pather
Frank Plani
Publikationsdatum
12.01.2021
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2021
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05899-z

Weitere Artikel der Ausgabe 4/2021

World Journal of Surgery 4/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.